BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15299278)

  • 1. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens.
    Angoulvant D; Clerc A; Benchalal S; Galambrun C; Farre A; Bertrand Y; Eljaafari A
    Biorheology; 2004; 41(3-4):469-76. PubMed ID: 15299278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
    Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
    Transplantation; 2003 Oct; 76(8):1208-13. PubMed ID: 14578755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge.
    Kang HS; Habib M; Chan J; Abavana C; Potian JA; Ponzio NM; Rameshwar P
    Exp Hematol; 2005 Jul; 33(7):796-803. PubMed ID: 15963855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
    Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them.
    Suva D; Passweg J; Arnaudeau S; Hoffmeyer P; Kindler V
    J Cell Physiol; 2008 Mar; 214(3):588-94. PubMed ID: 17786951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
    Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
    J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific structural differences in the alpha 1 + alpha 2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class I molecules.
    Engelhard VH; Le AX; Holterman MJ
    J Immunol; 1988 Sep; 141(6):1835-9. PubMed ID: 3262639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells.
    Romagnani C; Pietra G; Falco M; Millo E; Mazzarino P; Biassoni R; Moretta A; Moretta L; Mingari MC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11328-33. PubMed ID: 12167676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.
    Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
    Exp Cell Res; 2005 Apr; 305(1):33-41. PubMed ID: 15777785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting dilution analysis of alloreactive cytotoxic precursor cells in aging mice.
    Nordin AA; Collins GD
    J Immunol; 1983 Nov; 131(5):2215-8. PubMed ID: 6226737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    Kanagawa O
    J Immunol; 1983 Aug; 131(2):606-10. PubMed ID: 6602842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
    Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrocortisone suppresses the generation of nonspecific "anomalous" killers but not specific cytolytic T lymphocytes in human mixed lymphocyte-tumor cultures.
    Muul LM; Gately MK
    J Immunol; 1984 Mar; 132(3):1202-7. PubMed ID: 6198383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.